mRNA expression of antioxidant and biotransformation enzymes in zebrafish (Danio rerio) embryos after exposure to the tricyclic antidepressant amitriptyline
Language English Country Great Britain, England Media print-electronic
Document type Journal Article
PubMed
30445396
DOI
10.1016/j.chemosphere.2018.10.208
PII: S0045-6535(18)32083-6
Knihovny.cz E-resources
- Keywords
- CAT, CYP1A, Fish, GPx, GST, SOD,
- MeSH
- Amitriptyline pharmacology therapeutic use MeSH
- Antidepressive Agents, Tricyclic pharmacology therapeutic use MeSH
- Antioxidants metabolism MeSH
- Zebrafish MeSH
- Embryo, Nonmammalian drug effects metabolism MeSH
- Embryonic Development drug effects MeSH
- RNA, Messenger metabolism MeSH
- Oxidative Stress drug effects MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Amitriptyline MeSH
- Antidepressive Agents, Tricyclic MeSH
- Antioxidants MeSH
- RNA, Messenger MeSH
Now-a-days, the occurrence of antidepressant residues in surface waters has become a major concern. Amitriptyline (AMI) has been described to treat depression and other disorders for decades. However, little is known about its effect on non-target organisms. The aim of this study was to assess the potential impact of AMI on the mRNA expression of antioxidant and detoxification enzymes during the early embryonic development of zebrafish (Danio rerio). Fertilized D. rerio embryos were exposed to AMI at concentrations of 300 ng/L and 30 μg/L and sampled 24, 48, 96, and 144 h post fertilization (hpf) to assess the mRNA expressions of cytochrome P450 1A1, glutathione-S-transferase, glutathione peroxidase, superoxide dismutase, and catalase. The time courses of the mRNA expressions of antioxidant and detoxification enzymes revealed characteristic changes during embryonic development causing generally transient changes post hatching; however, AMI did not cause any significant impact except in the case of CAT after 144 h, which was significantly upregulated by the AMI concentration of 30 μg/L. The results suggest that the antidepressant AMI causes only moderate to minor impacts on antioxidant and detoxification enzymes during early embryonic development of the non-target organism D. rerio and that CAT is the only biomarker affected by AMI.
References provided by Crossref.org